Does neoadjuvant cisplatin‐based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta‐analysis of individual patient data from randomized clinical trials*

Beta blockade during and after myocardial infarction: An overview of the randomized trials

1985 • 3,248 citations

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

1992 • 972 citations

Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer

1988 • 921 citations

Meta-analysis of the literature or of individual patient data: is there a difference?

1993 • 752 citations

Tables of the number of patients required in clinical trials using the logrank test

1982 • 694 citations

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women

1988 • 631 citations

The Role of Adjuvant Chemotherapy Following Cystectomy for Invasive Bladder Cancer: A Prospective Comparative Trial

1991 • 542 citations

Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.

1996 • 470 citations

Statistical Tables for the Design of Clinical Trials.

1988 • 464 citations

Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.

1991 • 291 citations

Chemotherapy in advanced ovarian cancer: An overview of randomised clinical trials

1991 • 272 citations

Advanced Bladder Cancer (Stages pT3b, pT4a, pN1 and pN2): Improved Survival after Radical Cystectomy and 3 Adjuvant Cycles of Chemotherapy. Results of a Controlled Prospective Study

1992 • 268 citations

Neo‐adjuvant (Pre‐emptive) Cisplatin Therapy in Invasive Transitional Cell Carcinoma of the Bladder

1991 • 186 citations

Combined modality treatment with radiotherapy and chemotherapy

1989 • 145 citations

Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy

1991 • 142 citations

Introducing new treatments for cancer : practical, ethical and legal problems

1992 • 131 citations

Neoadjuvant Chemotherapy in Bladder Cancer: A Randomized Study

1993 • 63 citations

Neoadjuvant chemotherapy for invasive bladder cancer

1989 • 50 citations

Chemotherapy for invasive bladder cancer: neoadjuvant versus adjuvant.

1990 • 48 citations

Should single agents be standard therapy for urothelial tract tumors?

1989 • 25 citations

Preemptive (neoadjuvant) chemotherapy: can analysis of eligibility criteria, prognostic factors, and tumor staging from different trials provide valid or useful comparisons?

1990 • 15 citations

Chemotherapy for advanced bladder cancer: 'Midsummer Night's Dream' or 'Much Ado About Nothing'?

1990 • 15 citations

Keynote address: A critical assessment of trials of neoadjuvant (preemptive) chemotherapy for bladder cancer: Lesson for future studies of combined modality treatment

1991 • 15 citations

Cancer: Causes, Occurrence and Control

1991 • 10 citations

Systemic chemotherapy in the management of bladder cancer

1989 • 5 citations

Deleted Work

1955 • 0 citations